23 studies found for:    canary
Show Display Options
Rank Status Study
1 Recruiting Using the Canary Breathing System for Panic Disorder Patients
Condition: Panic Disorder
Intervention: Device: Canary Breathing System
2 Active, not recruiting CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow
Conditions: Coronary Atherosclerosis;   Myocardial Infarction;   Coronary Plaque Embolization
Interventions: Device: Embolic Protection Device (EPD);   Device: Intracoronary Spectroscopy and Ultrasonic Evaluation;   Device: Angioplasty and Stent Implant
3 Completed
Has Results
Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors
Condition: Cytomegalovirus Infections
Intervention: Biological: ALVAC-CMV (vCP260)
4 Recruiting Tertiary Prevention in Type II Diabetes Mellitus in Canary Islands Study
Condition: Type 2 Diabetes Mellitus
Interventions: Behavioral: Intervention to patients;   Behavioral: Intervention to professionals;   Other: Usual care
5 Recruiting Prostate Active Surveillance Study
Condition: Prostatic Neoplasms
Intervention:
6 Completed A Critical Appraisal of the Role of Near Infrared Spectroscopy (NIRS) in the Pediatric Intensive Care Unit (PICU)
Condition: Pediatric Intensive Care Unit
Intervention:
7 Completed Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients
Condition: HIV Infection
Interventions: Biological: one injection of vCP1452 at W0, W4, W8 and W20;   Biological: one injection of vCP1452 at W4, W8 and W20;   Biological: one injection of placebo at W0, W4, W8, W20 or at W4, W8,W20
8 Recruiting Effect of Curodont Repair or Placebo on the Remineralisation in Patients With Class 5 Carious Lesions
Condition: Dental Caries
Interventions: Device: Curodont Repair;   Other: Placebo;   Device: Fluoride
9 Terminated
Has Results
Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma
Conditions: Metastatic Melanoma;   Skin Cancer
Interventions: Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Biological: Aldesleukin;   Biological: ALVAC gp100 Vaccine;   Biological: anti-gp100:154-162 Tcell receptor (TCR) peripheral blood lymphocyte (PBL)
10 Terminated
Has Results
Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma
Conditions: Metastatic Melanoma;   Skin Cancer
Interventions: Biological: autologous anti-MART-1 F5 T-cell receptor gene-engineered peripheral blood lymphocytes;   Biological: ALVAC MART-1 Vaccine;   Biological: aldesleukin;   Drug: cyclophosphamide;   Drug: fludarabine phosphate
11 Withdrawn Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Condition: Adverse Events
Interventions: Behavioral: Group education, audit-feedback and computer support;   Behavioral: Audit-feedback and computer support;   Behavioral: Control
12 Recruiting Biological Half Life of DLBS1033 in Healthy Volunteers
Condition: Healthy Condition
Intervention: Drug: DLBS1033
13 Unknown  The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers
Condition: Healthy
Interventions: Drug: DLBS1033;   Drug: placebo
14 Recruiting Air Pollution, Inflammation and Acute Coronary Syndrome
Condition: Patients With Acute Coronary Syndrome
Intervention: Other: Particulate air pollutants
15 Recruiting A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: Albumin;   Biological: Immune globulin
16 Completed Incidence of Acute Lung Injury: The Alien Study
Condition: Acute Lung Injury
Intervention:
17 Terminated BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Trastuzumab;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: 5-Fluorouracil;   Drug: Epirubicin;   Drug: Cyclophosphamide
18 Completed Effects of PEEP and FIO2 in ALI and ARDS
Conditions: Acute Respiratory Distress Syndrome;   Acute Lung Injury;   Acute Respiratory Failure
Interventions: Procedure: standard ventilatory settings;   Procedure: PEEP and FiO2
19 Suspended The Effect of Ozone Therapy for Lumbar Herniated Disc
Condition: Lumbar Herniated Disc
Interventions: Procedure: Discectomy/ micro discectomy;   Drug: Ozone therapy;   Drug: Oxygen therapy
20 Recruiting Prospective Observational Epidemiologic Study of Maraviroc's Safety
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc

Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results
Indicates status has not been verified in more than two years